This work applies noninvasive single-cell Raman spectroscopy (RS) and principal component analysis (PCA) to analyze and correlate radiation-induced biochemical changes in a panel of human tumour cell lines that vary by tissue of origin, p53 status and intrinsic radiosensitivity. Six human tumour cell lines, derived from prostate (DU145, PC3 and LNCaP), breast (MDA-MB-231 and MCF7) and lung (H460), were irradiated in vitro with single fractions (15, 30 or 50 Gy) of 6 MV photons. Remaining live cells were harvested for RS analysis at 0, 24, 48 and 72 h post-irradiation, along with unirradiated controls. Singlecell Raman spectra were acquired from 20 cells per sample utilizing a 785 nm excitation laser. All spectra (200 per cell line) were individually post-processed using established methods and the total data set for each cell line was analyzed with PCA using standard algorithms. One radiation-induced PCA component was detected for each cell line by identification of statistically significant changes in the PCA score distributions for irradiated samples, as compared to unirradiated samples, in the first 24-72 h post-irradiation. These RS response signatures arise from radiation-induced changes in cellular concentrations of aromatic amino acids, conformational protein structures and certain nucleic acid and lipid functional groups. Correlation analysis between the radiationinduced PCA components separates the cell lines into three distinct RS response categories: R1 (H460 and MCF7), R2 (MDA-MB-231 and PC3) and R3 (DU145 and LNCaP). These RS categories partially segregate according to radiosensitivity, as the R1 and R2 cell lines are radioresistant (SF 2 > 0.6) and the R3 cell lines are radiosensitive (SF 2 < 0.5). The R1 and R2 cell lines further segregate according to p53 gene status, corroborated by cell cycle analysis postirradiation. Potential radiation-induced biochemical response mechanisms underlying our RS observations are proposed, such as (1) 
Introduction
Optimizing the effectiveness of radiation therapy is limited in part by the variability in radiation response between patients. Probabilities of both normal tissue complication and tumour control depend on individual patient responses to treatment (Peters 1996) . There is currently no proven method for assessing tumour radiation response in a patient during the course of an extended treatment. Efforts to develop a predictive assay for tumour radiation response using pretreatment indicators related to apoptosis (Levine et al 1995) , intrinsic radiosensitivity (Levine et al 1995 , West et al 1997 , Björk-Eriksson et al 2000 , hypoxia (Nordsmark and Overgaard 2000 , Vaupel and Mayer 2007 , Luukkaa et al 2009 or tumour proliferation (Begg et al 1999) have shown promise, but most have had either unsatisfactory levels of success or posed significant technical difficulties preventing clinical implementation. The relationship between the genetic status of tumours and intrinsic radiosensitivity has been studied extensively, yet the importance of the functional state of certain genes (e.g. p53) in determining radiosensitivity appears to depend on the tumour cell lines examined (McIlwrath et al 1994 , Oya et al 2003 , Scott et al 2003 , Williams et al 2007 . Recently developed methods applying multigene expression profiles to predict the tumour radiosensitivity of a patient by comparisons with clonogenic survival data from established cell lines (Torres-Roca et al 2005 likely have the most potential for clinical implementation. Such methods have been shown to be statistically predictive of tumour response in esophageal and rectal cancers, and of locoregional control in head and neck cancers . However, both pre-clinical and clinical studies report many false positives and negatives. Such methods may also be inherently limited by the use of laboratory data from established tumour cell lines upon which the models are constructed, possibly limiting the application for clinical cases across a variety of tumour types. In light of these previous and ongoing research efforts, future advances in the field of experimental radiobiology as applied to personalized radiation therapy may benefit from the use of new biochemical analysis methods with the ability to analyze biochemical radiation response in vitro or in vivo across a wide variety of biomolecules. One such technique is Raman spectroscopy (RS).
RS is a vibrational spectroscopy technique in which an optical wavelength laser is focused onto a sample, inducing transitions between molecular vibrational levels and creating inelastically scattered photons (Raman scattering) with frequencies and intensities characteristic of the molecules in the sample. The resulting Raman spectrum provides a detailed description of the molecular composition within the sampling volume. Within a specific range of laser wavelength and power, RS is noninvasive and nondestructive, allowing the analysis of live cells or tissues without perturbation of the sample (Puppels et al 1991 , Notingher et al 2002 . The use of high-power focusing optics can provide spatial resolutions as low as 1 μm, well below the typical size of a human cell (10-50 μm diameter). Furthermore, RS can provide biochemical information from unfixed cells at comparable levels of accuracy and sensitivity as established techniques such as magnetic resonance spectroscopy (MRS) and flow cytometry (Mourant et al 2006) . RS has an inherent advantage over other biochemical analysis tools by enabling the simultaneous detection of a variety of molecular structures across proteins (e.g., amino acids, conformational structures), nucleic acids (DNA and RNA) and lipids (e.g., cholesterol, choline, CH 2 groups), in a single acquisition. This utility allows complex biochemical changes in cells to be analyzed simultaneously across different classes of biomolecules rather than analyzing a single type of molecule (e.g., DNA), or class of molecules (e.g., metabolites), an inherent restriction of many established techniques. RS also has the potential to be applied in vivo with the use of fiber-optic probe technology (Motz et al 2004) . Two major drawbacks of RS for biological analysis are the inherently weak intensity of biological Raman scattering, often necessitating long integration times, and the competition with fluorescence from biological materials, optical components, and sample substrates or containers. However, the use of high-power excitation lasers, low-fluorescence optics and substrates, and automated baseline removal methods Mahadevan-Jansen 2003, Schulze et al 2005) can alleviate these difficulties.
RS has been investigated in oncology for cancer detection and diagnosis, successfully discriminating between healthy and cancerous skin (Nijssen et al 2002 , Choi et al 2005 , Lieber et al 2008 ), bladder (de Jong et al 2006 and gastric (Teh et al 2008 (Teh et al , 2009 ) tissues, and aiding in the histopathological analysis of prostate cancer (Tollefson et al 2010) . Other studies have applied RS for cellular biochemical analysis of apoptosis (Verrier et al 2004 , Zoladek et al 2011 , necrosis (Kunapareddy et al 2008) , cell death (Notingher et al 2003) , non-proliferation (Short et al 2005) and cell cycle (Swain et al 2008 , Matthews et al 2010 . In radiobiological applications, RS has detected molecular alterations in irradiated aqueous DNA (Sailer et al 1996, Shaw and Jirasek 2009) , sodium hyaluronate (Synytsya et al 2011) , biological membranes (Verma 1986 , Verma and Rastogi 1990 , Verma and Sonwalkar 1991 , Verma et al 1993 , Sailer et al 1997 , and skin and muscle tissues (Lakshmi et al 2002 , Synytsya et al 2004 . A recent clinical RS study discriminated between responding and non-responding cervical cancers post-irradiation (Vidyasagar et al 2008) , yet made no conclusions regarding the differences in the biochemical composition between tissues or the molecular basis for RS discrimination. However, the study does validate the potential for using RS in clinical radiotherapy practice.
Our recent work (Matthews et al 2011) has demonstrated that our single-cell RS techniques (Matthews et al 2010) , applied to cells cultured and irradiated in vitro with single fractions of ionizing radiation (15, 30 and 50 Gy), can detect radiation-induced changes in proteins, lipids and nucleic acids within a human prostate cancer cell line (DU145). In this work, we extend these methods to a panel of six human tumour cell lines, derived from prostate (DU145, PC3 and LNCaP), breast (MDA-MB-231 and MCF7) and lung (H460). The cell lines tested vary by tissue of origin, p53 gene status and intrinsic radiosensitivity. Within the tested cell lines, we detect biochemical radiation response signatures that segregate according to radiosensitivity and p53 status. For all cell lines, our application of principal component analysis (PCA) effectively distinguishes radiation-induced biochemical changes from any biochemical changes arising from cell cycle differences or other factors. Our observed radiation response signatures indicate changes in the cellular concentration of aromatic amino acids (tyrosine, tryptophan and phenylalanine), conformational protein structures (α-helices, β-sheets and random coils) and certain nucleic acid and lipid functional groups. These radiation-induced biochemical changes are detected within the first 1-3 days after exposure to all doses delivered (15, 30 and 50 Gy). Many of the observed biochemical changes are consistent with known cellular response mechanisms to radiation exposure (e.g. synthesis and degradation of structured proteins), whereas others may be novel discoveries. The relationship between the RS radiation response signatures and intrinsic radiosensitivity may be indicative of the detection of biochemical mechanisms of radiation resistance or sensitivity with RS. Some candidate processes for such mechanisms are discussed.
Methods

Cell lines and culture conditions
Six human tumour cell lines were used for this study, derived from prostate (DU145, PC3 and LNCaP), breast (MDA-MB-231 and MCF7) and lung (H460). These cell lines vary according to p53 status and average reported radiosensitivity (see section 3.5), given by the surviving fraction after 2 Gy (SF 2 ). Our SF 2 values were calculated from literature data from four or five different laboratories per cell line , Amorino et al 2000 , Park et al 2010 , Sak et al 2002 , Cai et al 2008 , Robinson and Shewach 2001 , Schmidt-Ullrich et al 1992 , Hahnel et al 2010 , Wouters et al 2010 , DeWeese et al 1998 , Colletier et al 2000 , Chendil et al 2004 , Wang et al 2008 , Fullerton et al 2004 , Rosser et al 2004 whose methods closely approximated accepted protocols for clonogenic survival assays (Franken et al 2006) .
Cells were cultured in a sterile environment, using previously described protocols (Matthews et al 2010) , and kept in an incubator at 5% CO 2 and 37
• C to promote growth. Cell stocks were sub-cultured every 3-4 days by rinsing the cells in phosphate buffered saline (PBS) (HyClone, Logan, UT), adding trypsin to detach the cells from the tissue culture flask, and transferring 10-20% of the harvested cells to a new flask containing fresh growth media.
Cell irradiation
For all experiments, ten identical cell cultures were prepared in T-75 flasks at an initial confluency of 10-15%. After ∼3.5 days, the culture media was replaced with fresh media and cultures were irradiated with a single fraction of 6 MV photons from a Varian 6EX linear accelerator (Varian Medical Systems, Inc., Palo Alto, CA, USA) at a dose rate of ∼5.9 Gy min −1 . Four cultures were irradiated to 50 Gy, one was irradiated to 15 Gy, one was irradiated to 30 Gy and the remaining four cultures were left unirradiated. Cultures irradiated to 50 Gy were harvested for RS analysis at 0, 24, 48 and 72 h post-irradiation, with one unirradiated culture harvested and analyzed at the same time. Cultures irradiated to 15 and 30 Gy were harvested and analyzed at 72 h post-irradiation.
Cell cycle and viability analysis
During the harvesting procedure for RS analysis, the cell cycle distribution and viability (live cell fraction) of each culture was determined with flow cytometry, as described previously (Matthews et al 2010) . For all experiments in this work, the fraction of live cells in the harvested samples was between 75% and 99%. Any cell spectrum resembling that of a dead cell (Notingher et al 2003) was rejected during RS acquisition. No correlations were found between the viability of harvested cultures and the RS data collected, confirming that the cell spectra acquired for processing and PCA analysis were indeed obtained from live cells.
RS and data processing
Sample preparation and RS analysis were performed as described previously (Matthews et al 2010) . Briefly, after rinsing with PBS to remove dead cells and debris, the remaining live cells were harvested with trypsin and centrifuged into a pellet in a 200 μL vial. Vials were kept on ice until RS analysis (1-6 h), upon which the chosen pellet was transferred to a quartz disk (Technical Glass Products, Painesville, OH, USA). Raman spectra were acquired from 20 individual cells from each sample, with cells chosen at random from the top layer of the cell pellet. Raman acquisition was performed with an inVia Raman microscope (Renishaw Inc., Hoffman Estates, IL, USA) with a 100× dry objective (Leica Microsystems, Wetzlar, Germany), a 1200 lines mm −1 diffraction grating, 30 s acquisition time per cell and 600-1800 cm −1 spectral window. A 785 nm continuous wave diode laser (Renishaw) was used for sample excitation, providing a laser power density at the sample of ∼0.5 mW μm −3 . The size of the sampling volume was ∼2 × 5 × 10 μm, allowing a single acquisition to represent the Raman spectrum of a single cell (∼10 μm diameter) (Matthews et al 2010) . Each cell spectrum was processed to remove cosmic rays, reduce noise via spectral smoothing, estimate and subtract a baseline arising from the quartz substrate and biological fluorescence and normalize to the total amount of biological material within the sampling volume (Matthews et al 2010) . The fully processed data set (200 spectra per cell line) was then analyzed with PCA using standard algorithms (Matlab, The Mathworks, Natick, MA, USA). Correlations (r-values) between PCA components were computed using Pearson's linear correlation coefficient (Matlab).
Results
Unirradiated cell spectra
The Raman spectrum of a single unirradiated DU145 cell, from 600 to 1800 cm −1 (figure 1(a)), contains multiple contributions from proteins, lipids and nucleic acids. A detailed listing of the molecular assignments for the spectral features we observe for DU145 cells has been recently reported (Matthews et al 2010) , compiled from literature reports examining different cell lines or tissues (Notingher et al 2003 , Notingher and Hench 2006 , Krafft et al 2003 , Uzunbajakava et al 2003 , Synytsya et al 2004 , Omberg et al 2002 , Borchman et al 1999 . Here, we also present the averaged Raman spectrum from 20 unirradiated cells for all six cell lines used in this study ( figure 1(b) ), harvested and analyzed immediately after the time of irradiation. All spectral features observed for DU145 cells (figure 1(a)) are also observed for the other cell lines. There are subtle differences in the relative intensity of spectral features between cell lines, arising from inherent differences in biomolecular compositions between tumour cell lines (Crow et al 2005) and slightly different cell cycle distributions between cultures at time of irradiation (Matthews et al 2010) .
Cell cycle spectral variability
Our previous work using the prostate cell line DU145 demonstrated that Raman spectral variability arising from inherent cell cycle differences between cells is identified by the first PCA component of a RS data set obtained from both unirradiated and irradiated DU145 cells (Matthews et al 2011) . In this study with multiple cell lines, the cell cycle PCA component observed for DU145 cells (figure 1(c)) was consistently reproduced as either the first or second PCA component of all data sets (figure 1(d)) and accounts for 10-50% ( figure 1(d) ) of the total variance in the data, depending on the cell line. This cell cycle variability arises from decreased concentrations of protein and nucleic acids (positive features in the PCA components, figures 1(c) and (d)) relative to lipids (negative features in the PCA components, figures 1(c) and (d)) in early G1 (or G0) phase cells as compared to late G1, S and G2 phase cells (Matthews et al 2010) . It should be noted that the reduced percent variance explained by the H460 cell cycle component (12.1%) relative to the other five cell lines (36.0-48.1%) (figure 1(d)) is firstly a result of the H460 cell line exhibiting the largest radiation-induced spectral changes (section 3.3), and secondly due to the fact that the H460 cell line demonstrated the lowest levels of inherent susceptibility to depletion of nucleic acid and protein content relative to lipid content (via early G1 (or G0) arrest or like processes) induced by either radiation exposure or varying cell culture conditions (i.e. confluency). 
RS radiation response signatures I: categories R1, R2 and R3
PCA components corresponding to radiation-induced biochemical changes (independent from the cell cycle related changes described by the cell cycle PCA components, figure 1(d)) were identified by statistically significant (p < 0.05) changes in the corresponding PCA score distributions for irradiated samples, as compared to unirradiated samples, in the first 24-72 h after irradiation. In this study, one definitively radiation-induced PCA component was detected for each cell line (figure 2). The percent variance explained by the radiation-induced PCA component, which indicates the strength of the radiation induced biochemical response (relative to other sources of spectral variability) and determines the PCA component number, is highly dependent upon cell line and varies from 3.0% (PC3) to 50.3% (H460). Correlation analysis between radiation-induced PCA components (table 1) indicates that these RS radiation response signatures fall into three distinct categories, which we abbreviate R1 (H460 and MCF7, r = 0.87), R2 (MDA-MB-231 and PC3, r = 0.59) and R3 (DU145 and LNCaP, r = 0.51). There is also consistent correlation between the PCA components in groups R1 
RS radiation response signatures II: radiation-induced changes in biomolecules across categories R1, R2 and R3
The biomolecules responsible for the observed radiation-induced PCA components For the PCA components from RS categories R1 and R2 (e.g., figures 3(a) and (c)), the observed decrease in the PCA scores for irradiated cells (figure 3(b) and (d)) corresponds with increases in amino acids, α-helix protein structure and CH groups (common negative features in R1 and R2 PCA components), and with decreases in nucleic acids, CH 2 groups and β-sheet and random coil protein structures (common positive features in R1 and R2 PCA components). The presence of many common biomolecules in the PCA components between groups R1 and R2 is reflected by the positive correlation between PCA components in these groups (table 1, average r = 0.33). For the RS category R3 components (e.g. figure 3(e) ), the observed decrease in the PCA scores for irradiated cells (figure 3(f)) corresponds with decreases in amino acids, α-helix protein structure and both CH 2 and CH groups (common positive features in the R3 PCA components), and with increases in nucleic acids, β-sheet and random coil protein structures, and choline (common negative features in the R3 PCA components). The presence of many common biomolecules in the RS category R3 components that show opposite radiation-induced changes compared to the R1 and R2 components is reflected by the negative correlation values between PCA components in group R3 and groups R1 and R2 (table 1, −0.13 < r < −0.70). The PCA scores for the MCF7 (R1), PC3 (R2) and LNCaP (R3) radiation-induced PCA components (supplementary figure S-1 available at stacks.iop.org/PMB/56/6839/mmedia) show similar changes in their distributions with time and dose as their RS category counterparts. For these cell lines there are occasional reductions in the distances between PCA score distributions between irradiated and unirradiated samples (supplementary figures S-1b, Table 2 . RS biochemical radiation response category, tissue of origin (TOI), percent variance explained by radiation-induced PCA component, G1, S and G2 fractions at 24 h post-irradiation, p53 status and average reported radiosensitivity (SF 2 ) for the six cell lines used in this study. The superscript numbers indicate literature references used, which are specified below. S-1d and S-1f available at stacks.iop.org/PMB/56/6839/mmedia), a result consistent with the reduced strength of the radiation-induced responses of these cell lines relative to their RS category counterparts (figure 2).
RS
RS radiation response associations with cell cycle arrest, p53 and radiosensitivity
The RS radiation response categories R1, R2 and R3 segregate according to the known radiosensitivity of the cell lines (table 2) . The R1 and R2 category cell lines are known to be radiation resistant (SF 2 > 0.6) and the R3 cell lines are comparatively radiation sensitive (SF 2 < 0.5). Furthermore, the R1 cell lines contain a wild-type (wt) p53 gene, whereas the R2 cells contain a mutant (mt) p53 gene. The two R3 cell lines, DU145 (mt p53) and LNCaP (wt p53), are radiosensitive and show very different biochemical radiation response signatures from their p53 counterparts (figure 2, table 1). As normally functioning wt p53 is required for G1 phase cell cycle arrest post-irradiation (McIlwrath et al 1994) , our measured fraction of G1 cells at 24 h post-irradiation (table 2) confirms that the mt p53 cell lines do not show G1 phase arrest (6-11% G1 fraction at 24 h post-irradiation) and in fact show high levels of radiation-induced G2 phase arrest (60-87% G2 fraction at 24 h post-irradiation). As expected, the wt p53 cell lines maintain high G1 fractions post-irradiation (40-73% G1 fraction at 24 h post-irradiation).
Discussion
RS detection of biochemical signatures of radiation response
Our methods used in this study, namely the acquisition of hundreds of high-quality singlecell RS spectra per cell line, established spectral processing techniques (Matthews et al 2010 (Matthews et al , 2011 , and PCA, enable us to separate radiation-induced spectral changes from other simultaneously occurring sources of spectral variability, such as cell cycle. This technique provides direct analysis of the biomolecular changes arising in single cells responding to radiation exposure, independent of cell cycle or cell-death-related processes. We identify RS signatures of radiation response (i.e. the radiation-induced PCA components, figure 2) by statistically significant shifts in the corresponding PCA score distributions (e.g. figures 3(b), (d) and (f)) as a function of time post-irradiation and (in some cell lines) the delivered dose. The biomolecules responsible for these signatures are identified by the known molecular assignments of the positive and negative features in the radiation-induced PCA components (figures 1(a), 3(a), (c) and (e) ). In this study, we find that the biomolecular radiation responses of the six cell lines segregate into distinct categories (R1, R2 and R3), observable both by visual inspection of the signatures (figure 2) and by correlation analysis (table 1) . The qualitative similarities observed in the biomolecular changes between categories R1 and R2, and the many opposite changes observed between category R3 and categories R1 and R2 (i.e. figures 3(a), (c) and (e)), are quantitatively confirmed via correlation analysis (table 1).
Segregation of common radiation response signatures according to p53 status and radiosensitivity
The four cell lines that fall into the RS radiation response categories R1 and R2 are known to be radiation resistant (SF 2 > 0.6), whereas the two cell lines in category R3 are comparatively radiation sensitive (SF 2 < 0.5) (table 2). The RS signatures of radiation response between categories R1 (resistant wt p53) and R2 (resistant mt p53) are different, but share many common molecular features (figure 2), indicating similar yet unique radiation responses. As both groups R1 and R2 are comprised solely of radiation resistant cell lines, it is possible that the biochemical radiation responses we observe with RS are caused by cellular response mechanisms that increase survival after radiation exposure. Candidate mechanisms for such responses are discussed below (section 4.3).
The available SF 2 data from different laboratories (e.g. for MCF7, SF 2 values range from 0.50 (Schmidt-Ullrich et al 1992) to 0.81 (Amorino et al 2000) ) separate the confirmed resistant cell lines (average SF 2 > 0.6) from the comparatively sensitive cell lines (average SF 2 < 0.5). The average SF 2 values used here (table 2) were calculated from 4-5 literature sources that closely approximated currently accepted protocols for clonogenic survival assays (Franken et al 2006) . In particular, it was ensured that cultures were irradiated in exponential growth phase and that experiments were performed at least in triplicate.
It is important to note that PCA also calculates the relative 'strength' of the RS observed biomolecular radiation response, given by the variance explained by the identified radiationinduced PCA component. In our study, the cell lines demonstrated different radiation response strengths between categories of radiation response, and also within each category (figure 2, table 2). Between categories R1 and R2, the resistant wt p53 cell lines (R1) responded stronger than the resistant mt p53 cell lines (R2). A possible explanation for this behavior is proposed below (section 4.3.1). Within each category, H460 responded stronger than MCF7 (R1), MDA-MB-231 responded stronger than PC3 (R2) and DU145 responded stronger than LNCaP (R3).
Biochemical mechanisms of radiation resistance or sensitivity
Radioresistant cell lines: RS categories R1 and R2
. Some of the most dramatic radiation-induced biochemical changes we observe with RS arise from proteins ( figure 3) . From 24 to 72 h after irradiation, the known radiation resistant cell lines (RS categories R1 and R2) demonstrate increased concentrations of aromatic amino acids (phenylalanine, tyrosine and tryptophan) and α-helix protein structures, and decreased concentrations of β-sheet and random coil protein structures, relative to unirradiated controls. These changes corroborate with prior evidence that synthesis and degradation of structured proteins is correlated with increased survival post-irradiation and plays an important role in cellular radioadaptive response (Tapio and Jacob 2007) . These changes may also be reflective of cellular survival mechanisms triggered by radiation-induced oxidative stress, involving the breakdown of structured proteins (i.e. β-sheet and random coil protein structures) into free amino acids to aid in the scavenging of reactive oxygen species created by radiation damage (Dröge 2002) . Our observation of increased α-helix protein structure with radiation could be explained by concurrent synthesis of certain proteins involved in radiation response pathways that increase cell survival post-irradiation. For example, colorectal cells have been shown to express 14-3-3σ protein for up to 60 h post-irradiation to aid in the inhibition of cell cycle progression through G2/M phase, resulting in increased survival (Hermeking et al 1997) . 14-3-3 proteins are primarily composed of α-helices (Xiao et al 1995) , are involved in many cell division and signaling pathways (Xiao et al 1995 , van Hemert et al 2001 and are known to suppress apoptosis via inhibition of several pro-apoptosis pathways (van Hemert et al 2001) . Another candidate protein with predominantly α-helix structure is survivin (Chantalat et al 2000) , a known anti-apoptosis factor that has been linked to increased radioresistance in glioblastomas (Chakravarti et al 2004) , pancreatic cancers (Kami et al 2005) , rectal cancers (Rödel et al 2005) and head and neck squamous carcinomas (Khan et al 2010) . Furthermore, it was shown for glioblastomas that radioresistant cell lines expressed survivin post-irradiation in all phases of the cell cycle, whereas radiosensitive cell lines limited survivin expression to G2/M phase, independent of p53 status (Chakravarti et al 2004) .
In this study, we observe unique radiation response signatures between the resistant wt p53 (R1) and the resistant mt p53 (R2) cell lines. However, the consistent positive correlations between the R1 and R2 radiation response signatures (table 1, 0.18 < r < 0.50) indicate that there are similarities in the radiation-induced biomolecular responses between resistant wt p53 and resistant mt p53 cell lines. p53 is known to regulate cell cycle arrest postirradiation (McIlwrath et al 1994 , Hermeking et al 1997 and our flow cytometry measurements (table 2) confirm the differences in cell cycle regulation that occur between the wt p53 and the mt p53 cell lines in our study. Furthermore, it has been observed that radiation-induced apoptosis, which would increase sensitivity, requires wt p53 status (McIlwrath et al 1994) . As such, it is to be expected that the biochemical nature of a radiation-induced response that promotes cell survival post-irradiation may be determined by p53 status. An example of such p53 dependence on biochemical radiation response and radiosensitivity has been recently observed via analysis of micro-RNA expression post-irradiation (Chaudhry et al 2010) . It is also likely that different responses working to achieve the same result (i.e. increased survival post-irradiation) would have common characteristics (e.g. expression of anti-apoptosis factors or other survival signals). As discussed above in section 4.2, we observe stronger radiation responses from the R1 (resistant wt p53) cell lines than from the R2 (resistant mt p53) cell lines, although the responses have many similar features. If our observed RS responses from the R1 and R2 cell lines are indeed caused in part by the radiation-induced synthesis of antiapoptosis proteins, it is plausible that a wt p53 cell line with equivalent radiosensitivity as a mt p53 cell line would need to mount a larger biochemical response (i.e. increased expression of anti-apoptosis factors) in order to suppress the intact pro-apoptotic pathways, in addition to the biochemical response required for other mechanisms of survival post-irradiation. This model may explain the observed differences and similarities between the radiation response signatures obtained for groups R1 and R2 in this study.
Radiosensitive cell lines: RS category R3.
Neither of the radiosensitive cell lines comprising RS category R3, DU145 (mt p53) and LNCaP (wt p53), show a radiation response similar to the other four cell lines. This lack of response may be the result of some other reason why these cells do not mount a similar radiation response as their p53 counterparts, which may be necessary for increased survival post-irradiation (e.g. expression of anti-apoptosis factors or other survival signals). Furthermore, both of the radiation response signatures for the R3 cell lines, although different (figure 2), are anti-correlated with the R1 and R2 signatures and positively correlated with each other (table 1). As such, these R3 radiation response signatures, which show anti-correlation with possible biochemical signatures of radiation resistance, may in turn prove to be signatures of radiation sensitivity.
Uniqueness of the observed RS biochemical radiation responses
The biochemical variability described by the radiation-induced PCA components (figure 2) is only observed when the data sets containing both unirradiated and irradiated cell spectra are input into PCA, with one exception. The radiation-induced PCA component for the H460 cell line, which demonstrated the strongest radiation response of all the cell lines (50.3% of the total variance), is also observed (r = 0.80) when only the unirradiated H460 cell spectra are input into PCA but with a much reduced percent variance explained (16.8% versus 50.3%). This result suggests that the biochemical variability described by the radiation-induced PCA component for the H460 cell line is not a uniquely radiationinduced response, but rather is enhanced by radiation and may be induced by other factors as well. Interestingly, a large fraction of the variability described by the component obtained from only the unirradiated cells data set arises from a small number of outliers (∼4) from the 80 unirradiated cells. The corresponding PCA component and score plot obtained from only the 80 unirradiated H460 cells are provided in supplementary figure S-2 available at stacks.iop.org/PMB/56/6839/mmedia, where the four outlier cells with the lowest PCA scores are indicated. If these four outliers are removed from the 80 cell data set prior to PCA, the component is still observed but with a significant drop in variance (11.1% versus 16.8%).
For the other five human tumour cell lines investigated in this work, the radiation-induced PCA components are not observed if only the unirradiated cell spectra are input into PCA. If the biochemical variability was indeed present in these other cell lines, it was too weak for detection with RS using the current methods, possibly due to insufficient induction by the in vitro culture environment. Since the radiation response of the H460 cell line is inherently much stronger than that of the other cell lines, it is possible that the in vitro culture environment provided sufficient stimuli or stresses to induce a similar biochemical response in a subset of the unirradiated H460 cells, which was therefore detected with RS without radiation exposure.
The effect of radiation on cell cycle variability
We previously reported for RS of irradiated DU145 cells how radiation induces an observable effect on the PCA scores for the cell cycle PCA component, while leaving the features of the cell cycle PCA component unchanged (Matthews et al 2011) . Here, we report the same result for all six cell lines used in this study (figure 1(d) and table 2). The effect of radiation on the corresponding PCA scores (not shown) is dependent on the susceptibility of the cell line to radiation-induced depletion of nucleic acid and protein content relative to lipid content, arising from early G1 (or G0) arrest or like processes (Matthews et al 2010) . Determining any possible relationships between this susceptibility and the nature of the observed RS signatures of radiation response, or with known radiosensitivity, may be a topic of interest for future research and will require similar analysis of more cell lines.
Conclusions
Within a preliminary panel of six human tumour cell lines derived from prostate (DU145, PC3 and LNCaP), breast (MDA-MB-231 and MCF7) and lung (H460), we have demonstrated that RS can detect biochemical signatures of in vitro radiation response that segregate according to p53 status and intrinsic radiosensitivity (SF 2 ). The observed RS signatures arise from radiation-induced changes in cellular concentrations of aromatic amino acids, conformational protein structures, and certain nucleic acid and lipid functional groups, and are detected from live, unfixed, single cells analyzed 1-3 days post-irradiation. Our sensitivity to the biomolecules responsible for the observed radiation responses provides new insight into possible mechanisms of radiation survival, and into the differences in such survival mechanisms between wt p53 and mt p53 cell lines. We have proposed potential radiationinduced biochemical response mechanisms underlying our RS observations, namely (1) the regulated synthesis and degradation of structured proteins and (2) the expression of antiapoptosis factors or other survival signals.
This study further demonstrates the utility of using RS for radiobiological investigations. Specifically, the relationship between the RS radiation response signatures and intrinsic radiosensitivity supports the possibility of using RS for detecting radiation resistance or sensitivity in clinical practice. Future work may lead to the development of RS techniques for monitoring or predicting tumour response in radiation therapy patients.
